NCT01400750View on ClinicalTrials.gov

Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis

PHASE4CompletedINTERVENTIONAL
Enrollment

61

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

August 31, 2010

Study Completion Date

May 31, 2011

Conditions
Cystic Fibrosis
Interventions
DRUG

oral ciprofloxacin plus inhaled colistin

oral ciprofloxacin (30mg/kg/day divided in 2 doses) for 3 months (CC) plus inhaled colistimethate sodium(Colistineb® 2x2 mill U daily)

DRUG

TOBI

tobramycin inhalation solution (TOBI® 2x300 mg) for 28 days

Trial Locations (1)

3000

Department of pediatrics, CF center Uuiversity Hospital Leuven, Leuven

All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT01400750 - Comparison of 2 Treatment Regimens for Eradication of P Aeruginosa Infection in Children With Cystic Fibrosis | Biotech Hunter | Biotech Hunter